The present disclosure relates generally to devices for directing light on tissue to induce one or more biological effects and more particularly to phototherapeutic illumination devices with modular structures.
Disease-causing pathogens typically invade tissues of the human body via mucosal surfaces within body cavities, such as mucous membranes or mucosae of the respiratory tract. A number of respiratory diseases and infections, including viral and bacterial, can be attributed to such disease-causing pathogens. Examples include Orthomyxoviridae (e.g., influenza), common colds, coronaviridae (e.g., coronavirus), picornavirus infections, tuberculosis, pneumonia, bronchitis, and sinusitis. Most respiratory tract infections begin when a subject is exposed to pathogen particles, which enter the body through the mouth and nose. For viral infections, cells at the site of infection must be accessible, susceptible, and permissive for the virus, and local host anti-viral defense systems must be absent or initially ineffective. Conventional treatments for infections may involve systemic administration of antimicrobials, such as antibiotics for bacterial infections, that can sometimes lead to drug resistance and gastro-intestinal distress. Other conventional treatment protocols may involve managing and enduring symptoms while waiting for infections to clear, particularly in the case of viral infections.
Upper respiratory tract infections, including the common cold, influenza, and those resulting from exposure to coronaviridae, are widely prevalent infections that continually impact the worldwide population. In some instances, upper respiratory tract infections can progress to cause serious and sometimes fatal diseases that develop in the lower respiratory tract or elsewhere in the body. The art continues to seek improved treatment options for respiratory tract conditions capable of overcoming challenges associated with conventional treatment options.
The present disclosure relates generally to devices for directing light on tissue to induce one or more biological effects and more particularly to phototherapeutic illumination devices with modular structures. Modular structures are disclosed that provide the ability to have various changeable attributes for illumination devices based on intended treatment protocols. Modular structures may include tokens, switches, handles, rechargeable power structures, control modules, illumination modules, optics, light guides, and/or light guide positioners, among others.
In one aspect, an illumination device comprises: at least one light source arranged to irradiate light on tissue to induce a biological effect; driver circuitry configured to drive the at least one light source; and a removable token configured to control operation of the at least one light source. In certain embodiments, the removable token is configured for near field communication with the driver circuitry. The illumination device may further comprise a housing that at least partially encloses the at least one light source and the driver circuitry. In certain embodiments, the housing comprises a receptacle configured to receive the removable token. In certain embodiments, the removable token forms a protrusion with a first shape that corresponds with a second shape of a slot of the receptacle. In certain embodiments, the removable token comprises a plug that fits into the receptacle. In certain embodiments, the removable token forms a physical connection within the receptacle for providing transfer of information. In certain embodiments, the removable token is configured to provide near field communication for transfer of information with the driver circuitry. In certain embodiments, the housing comprises a window proximate the at least one light source configured to provide visual indication when the at least one light source is electrically activated. The illumination device may further comprise: a heatsink within the housing, wherein the at least one light source is on the heatsink; and an optical cup peripherally surrounding the at least one light source, wherein a portion of the optical cup is attached to the heatsink.
In certain embodiments, the housing forms a handle and the removable token is attached to a base of the handle. The illumination device may further comprise a carriage within the housing, wherein the removable token is attached to the carriage. The illumination device may further comprise a port at the carriage, the port being configured as one or more of a charging port and a data transfer port. In certain embodiments, the driver circuitry is attached to the carriage.
In certain embodiments, the removable token is configured to slide within the receptacle to lock in place.
The illumination device may further comprise: a light guide attached to the housing and optically coupled to the at least one light source; and a light guide positioner attached to the light guide, wherein the light guide positioner is configured to be positioned within an oral cavity of a user. The illumination device may comprise a user interface display on the housing.
In certain embodiments, the removable token is configured to be prescribed by a health care provider. In certain embodiments, the removable token is configured to control operation of the at least one light source according to a treatment protocol for irradiating light on tissue within a body cavity. In certain embodiments, the removable token forms a switch electrically coupled to the driver circuitry for initiating operation of the at least one light source. The illumination device may further comprise a communication module configured to communication with an external device. In certain embodiments, the removable token is part of an illumination cartridge that includes the at least one light source, the illumination cartridge being removable. In certain embodiments, the removable token is removable from the illumination cartridge. In certain embodiments, the removable token is part of an illumination head that includes the at least one light source, the illumination head being removable. In certain embodiments, the removable token is removable from the illumination head.
In another aspect, an illumination device comprises: a housing; and an illumination cartridge configured to be releasably attached to the housing, the illumination cartridge comprising at least one light source arranged to irradiate light on tissue to induce a biological effect; and driver circuitry configured to drive the at least one light source. The illumination device may further comprise a light guide attached to the housing and optically coupled to the at least one light source. The illumination device may further comprise a light guide positioner attached to the light guide, wherein the light guide positioner is configured to be positioned within an oral cavity of a user. In certain embodiments, the illumination cartridge further comprises a cartridge window configured to provide visual indication when the at least one light source is electrically activated. In certain embodiments, the cartridge window is positioned to receive a portion of light from the at least one light source. In certain embodiments, the illumination cartridge further comprises an additional light source that is spaced apart from the at least one light source, wherein the cartridge window is positioned to receive a portion of light from the additional light source. In certain embodiments, the cartridge window comprises a button for initiating operation of the at least one light source. In certain embodiments, the illumination cartridge further comprises a heat sink. In certain embodiments, the illumination cartridge further comprises an optical cup peripherally surrounding the at least one light source, wherein a portion of the optical cup is attached to the heatsink. In certain embodiments, the illumination cartridge further comprises a base that is coupled to the optical cup, wherein a portion of the base is connected to the housing. The illumination device may further comprise a user interface display on the housing. In certain embodiments, the driver circuitry is within the illumination cartridge. In certain embodiments, the driver circuitry is within the housing. In certain embodiments, the illumination cartridge comprises a token configured to control operation of the at least one light source. In certain embodiments, the token is removable from the illumination cartridge.
In another aspect, an illumination device comprises: an illumination head comprising at least one light source arranged to irradiate light on tissue to induce a biological effect; driver circuitry configured to drive the at least one light source; and a handle configured for releasable attachment with the illumination head. In certain embodiments, the illumination head comprises an illumination head window configured to provide visual indication when the at least one light source is electrically activated. The illumination head may further comprise an additional light source that is spaced apart from the at least one light source, wherein the illumination head window is positioned to receive a portion of light from the additional light source. In certain embodiments, the illumination head window comprises a button for initiation operation of the at least one light source. In certain embodiments, the illumination head further comprises a heat sink. In certain embodiments, the handle comprises an energy storage device and a port, wherein the port is one or more of a charging port and a data transfer port. In certain embodiments, the port is positioned at a base of the handle. The illumination device may further comprise: a light guide attached to the illumination head and optically coupled to the at least one light source; and a light guide positioner attached to the light guide, wherein the light guide positioner is configured to be positioned within an oral cavity of a user. The illumination device may further comprise a user interface display on the illumination head. In certain embodiments, the driver circuitry is positioned within the illumination head. In certain embodiments, the driver circuitry is positioned within the handle. In certain embodiments, the illumination head comprises a token configured to control operation of the at least one light source. In certain embodiments, the token is removable from the illumination head.
In another aspect, an illumination device comprises: a housing; at least one light source within the housing; a mouthpiece attached to the housing and configured to engage with one or more surfaces of an oral cavity; and a window formed in the housing and spaced away from the mouthpiece, the window configured to provide a visual indication when the at least one light source is electrically activated. In certain embodiments, the window is positioned to receive a portion of light from the at least one light source. The illumination device may further comprise an additional light source that is spaced apart from the at least one light source, wherein the window is positioned to receive a portion of light from the additional light source. The illumination device may further comprise a light guide attached to the housing and optically coupled to the at least one light source, wherein the mouthpiece is arranged about a periphery of the light guide. The illumination device may further comprise a removable token configured to control operation of the at least one light source. In certain embodiments, the housing comprises a receptacle configured to receive the removable token.
In another aspect, an illumination device comprises: a housing; a heatsink within the housing; at least one light source on the heatsink, the at least one light source arranged to irradiate light on tissue to induce a biological effect; and an optical cup peripherally surrounding the at least one light source and a portion of the optical cup being attached to the heatsink. In certain embodiments, the heatsink forms a protruding lip and the portion of the optical cup is attached to the protruding lip. In certain embodiments, the heatsink comprises a mounting surface for the at least one light source and the protruding lip extends in a direction parallel to the mounting surface. The illumination device may further comprise a lens within the housing, wherein the optical cup is between the lens and the at least one light source. In certain embodiments, the housing comprises a window proximate the at least one light source, and the optical cup comprises an opening that is registered with the window. The illumination device may further comprise a light guide attached to the housing and optically coupled to the at least one light source, wherein the optical cup extends between the heatsink and the light guide. The illumination device may further comprise a removable token configured to control operation of the at least one light source. In certain embodiments, the housing comprises a receptacle configured to receive the removable token.
In another aspect, any of the foregoing aspects individually or together, and/or various separate aspects and features as described herein, may be combined for additional advantage. Any of the various features and elements as disclosed herein may be combined with one or more other disclosed features and elements unless indicated to the contrary herein.
Those skilled in the art will appreciate the scope of the present disclosure and realize additional aspects thereof after reading the following detailed description of the preferred embodiments in association with the accompanying drawing figures.
The accompanying drawing figures incorporated in and forming a part of this specification illustrate several aspects of the disclosure, and together with the description serve to explain the principles of the disclosure.
The embodiments set forth below represent the necessary information to enable those skilled in the art to practice the embodiments and illustrate the best mode of practicing the embodiments. Upon reading the following description in light of the accompanying drawing figures, those skilled in the art will understand the concepts of the disclosure and will recognize applications of these concepts not particularly addressed herein. It should be understood that these concepts and applications fall within the scope of the disclosure and the accompanying claims.
It will be understood that, although the terms first, second, etc. may be used herein to describe various elements, these elements should not be limited by these terms. These terms are only used to distinguish one element from another. For example, a first element could be termed a second element, and, similarly, a second element could be termed a first element, without departing from the scope of the present disclosure. As used herein, the term “and/or” includes any and all combinations of one or more of the associated listed items.
It will be understood that when an element such as a layer, region, or substrate is referred to as being “on” or extending “onto” another element, it can be directly on or extend directly onto the other element or intervening elements may also be present. In contrast, when an element is referred to as being “directly on” or extending “directly onto” another element, there are no intervening elements present. Likewise, it will be understood that when an element such as a layer, region, or substrate is referred to as being “over” or extending “over” another element, it can be directly over or extend directly over the other element or intervening elements may also be present. In contrast, when an element is referred to as being “directly over” or extending “directly over” another element, there are no intervening elements present. It will also be understood that when an element is referred to as being “connected” or “coupled” to another element, it can be directly connected or coupled to the other element or intervening elements may be present. In contrast, when an element is referred to as being “directly connected” or “directly coupled” to another element, there are no intervening elements present.
Relative terms such as “below” or “above” or “upper” or “lower” or “horizontal” or “vertical” may be used herein to describe a relationship of one element, layer, or region to another element, layer, or region as illustrated in the Figures. It will be understood that these terms and those discussed above are intended to encompass different orientations of the device in addition to the orientation depicted in the Figures.
The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the disclosure. As used herein, the singular forms “a,” “an,” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “comprises,” “comprising,” “includes,” and/or “including” when used herein specify the presence of stated features, integers, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components, and/or groups thereof.
Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs. It will be further understood that terms used herein should be interpreted as having a meaning that is consistent with their meaning in the context of this specification and the relevant art and will not be interpreted in an idealized or overly formal sense unless expressly so defined herein.
Embodiments are described herein with reference to schematic illustrations of embodiments of the disclosure. As such, the actual dimensions of the layers and elements can be different, and variations from the shapes of the illustrations as a result, for example, of manufacturing techniques and/or tolerances, are expected. For example, a region illustrated or described as square or rectangular can have rounded or curved features, and regions shown as straight lines may have some irregularity. Thus, the regions illustrated in the figures are schematic and their shapes are not intended to illustrate the precise shape of a region of a device and are not intended to limit the scope of the disclosure. Additionally, sizes of structures or regions may be exaggerated relative to other structures or regions for illustrative purposes and, thus, are provided to illustrate the general structures of the present subject matter and may or may not be drawn to scale. Common elements between figures may be shown herein with common element numbers and may not be subsequently re-described.
The present disclosure relates generally to devices for directing light on tissue to induce one or more biological effects and more particularly to phototherapeutic illumination devices with modular structures. Modular structures are disclosed that provide the ability to have various changeable attributes for illumination devices based on intended treatment protocols. Modular structures may include tokens, switches, handles, rechargeable power structures, control modules, illumination modules, optics, light guides, and/or light guide positioners, among others.
Aspects of the present disclosure relate to devices and methods for directing light on a mammalian tissue, for example within a body and/or a body cavity of a patient, where the light may include at least one characteristic that exerts or induces at least one biological effect within or on the tissue. Exemplary tissues include those of the upper respiratory tract, including tissues and cavities that are accessible via the oral cavity, such as the nasopharynx and the oropharynx. Biological effects may include at least one of inactivating and inhibiting growth of one or more combinations of microorganisms and pathogens, including but not limited to viruses, bacteria, fungi, and other microbes, among others. Biological effects may also include one or more of upregulating and/or downregulating a local immune response, stimulating enzymatic generation of nitric oxide to increase endogenous stores of nitric oxide, releasing nitric oxide from endogenous stores of nitric oxide, and inducing an anti-inflammatory effect. Wavelengths of light may be selected based on at least one intended biological effect for one or more of the targeted tissues and the targeted microorganisms and/or pathogens. In certain aspects, wavelengths of light may include visible light in any number of wavelength ranges based on the intended biological effect. Further aspects involve directing light on tissue for multiple microorganisms and/or multiple pathogenic biological effects, either with light of a single peak wavelength or a combination of light with more than one peak wavelength. Devices and methods for light treatments are disclosed that provide light doses for inducing biological effects on various targeted pathogens and targeted tissues with increased efficacy and reduced cytotoxicity. Light doses may include various combinations of irradiances, wavelengths, and exposure times, and such light doses may be administered continuously or discontinuously with a number of pulsed exposures.
Exemplary devices and methods relate to treating, preventing, and/or reducing the biological activity of pathogens while they are in one or more areas of the upper respiratory tract and hopefully before they travel to the lungs or elsewhere in the body. Devices and methods as disclosed herein may prevent or reduce infections by reducing microbial load along one or more portions of the upper respiratory tract, decreasing the ability for penetration into cells at the site of infection, and amplifying host defense systems, all of which may reduce or avoid the need for traditional antimicrobial medicines. In further aspects, devices and methods for light irradiation of tissues as disclosed herein may be provided to supplement and/or enhance the effects of traditional antimicrobial medicines.
Embodiments of the present disclosure may administer light at one or more wavelengths as a pre-exposure prophylaxis or a post-exposure prophylaxis in order to target pathogens in or on tissue of the upper respiratory tract and/or amplify host defense systems. Embodiments of the present disclosure may be used to prevent and/or treat respiratory infections and other infectious diseases. For example, in certain embodiments, a hand-held illumination device may administer light at one or more wavelengths as a prophylactic measure to counteract invading viral pathogens and corresponding diseases that may originate in the respiratory tract. In a specific example, light may be administered that reduces viral infectivity and incidence of COVID-19 in individuals who have been infected or believe they may have been exposed to SARS-COV-2 virus. In certain aspects, illumination devices of the present disclosure may be referred to as phototherapeutic and/or phototherapy devices.
The term “phototherapy” or “phototherapeutic” generally relates to the therapeutic use of light for, by way of example, treating and/or preventing microbial infections, including viral infections of the upper respiratory tract. The mechanisms by which certain wavelengths of light are effective can vary, depending on the wavelength that is administered and the targeted microorganisms and/or pathogens. Biological effects, including antimicrobial effects, can be provided over a wide range of wavelengths, including ultraviolet (UV) ranges, visible light ranges, and infrared (IR) ranges, and combinations thereof.
Various wavelengths of visible light may be irradiated on human tissue with little or no impact on tissue viability. In certain embodiments, various wavelengths of visible light may elicit antimicrobial and/or anti-pathogenic behavior in tissue of the respiratory tract, including any of the aforementioned biological effects. For example, light with a peak wavelength in a range from 400 nanometers (nm) to 450 nm may inactivate microorganisms that are in a cell-free environment and/or inhibit replication of microorganisms that are in a cell-associated environment and/or stimulate enzymatic generation of nitric oxide, while also upregulating a local immune response in target tissue. In this regard, light with a peak wavelength in a range from 400 nm to 450 nm may be well suited for fighting invading viral pathogens and corresponding diseases that may originate in the respiratory tract, including Orthomyxoviridae (e.g., influenza), common colds, coronaviridae (e.g., coronavirus), picornavirus infections, tuberculosis, pneumonia, bronchitis, and sinusitis. In certain embodiments, red or near-infrared (NIR) light (e.g., peak wavelength range from 630 nm to 1,000 nm) may be useful to provide anti-inflammatory effects and/or to promote vasodilation. Anti-inflammatory effects may be useful in treating disorders, particularly microbial disorders that result in inflammation along the respiratory tract. In this regard, red light may be used as part of treatment protocols that reduce any tissue inflammation that may result from exposure to blue light, which may positively impact cell viability, thereby lowering cytotoxicity even further. A decrease in inflammation can be beneficial when treating viral infections, particularly when a virus can elicit a cytokine storm and/or inflammation can result in secondary bacterial infections. Accordingly, the combination of blue light, such as light at around 425 nm, and red light at one or more anti-inflammatory wavelengths, can provide a desirable combination of biological effects.
Depending on the application, other wavelength ranges of light may also be administered to human tissue. For example, UV light (e.g., UV-A light having a peak wavelength in a range of from 315 nm to 400 nm, UV-B light having a peak wavelength in a range of from 280 nm to 315 nm, and UV-C light having a peak wavelength in a range from 200 nm to 280 nm) may be effective for inactivating microorganisms that are in a cell-free environment and/or inhibit replication of microorganisms that are in a cell-associated environment and/or stimulate enzymatic generation of nitric oxide. However, overexposure to UV light may lead to cytotoxicity concerns in associated tissue. It may therefore be desirable to use shorter cycles and/or lower doses of UV light than corresponding treatments with only visible light. In certain embodiments, light with a peak wavelength in a range from 385 nm to 450 nm may be provided to elicit an antimicrobial and/or anti-pathogenic effect. In further embodiments, such wavelengths of light may be used in treatment protocols that also administer anti-inflammatory light. In certain aspects, light sources may be provided with light characteristics in the visible spectrum, for example with light emissions with peak wavelengths primarily in a range from 400 nm to 700 nm. Depending on the target application, light characteristics may also include IR or NIR peak wavelengths at or above 700 nm or UV peak wavelengths at or below 400 nm. As used herein, light may include visual and non-visual electromagnetic radiation with single or multiple peak wavelengths in a range from 180 nm to 4,000 nm.
Doses of light to induce one or more biological effects may be administered with one or more light characteristics, including peak wavelengths, radiant flux, and irradiance to target tissues. Irradiances to target tissues may be provided in a range from 0.1 milliwatts per square centimeter (mW/cm2) to 200 mW/cm2, or in a range from 5 mW/cm2 to 200 mW/cm2, or in a range from 5 mW/cm2 to 100 mW/cm2, or in a range from 5 mW/cm2 to 60 mW/cm2, or in a range from 60 mW/cm2 to 100 mW/cm2, or in a range from 100 mW/cm2 to 200 mW/cm2. In certain embodiments, irradiances in a range from 0.1 watts per square centimeter (W/cm2) to 10 W/cm2 may be safely pulsed to target tissue. Such irradiance ranges may be administered in one or more of continuous wave and pulsed configurations, including light-emitting diode (LED)-based photonic devices that are configured with suitable power (radiant flux) to irradiate a target tissue with any of the above-described ranges.
Light sources may include one or more of LEDs, organic LEDs (OLEDs), lasers, and other lamps according to aspects of the present disclosure. Lasers may be used for irradiation in combination with optical fibers or other delivery mechanisms. LEDs are solid state electronic devices capable of emitting light when electrically activated. LEDs may be configured across many different targeted emission spectrum bands with high efficiency and relatively low costs. Accordingly, LEDs may be used as light sources in photonic devices for phototherapy applications. Light from an LED is administered using a device capable of delivering the requisite power to a targeted treatment area or tissue. High power LED-based devices can be employed to fulfill various spectral and power needs for a variety of different medical applications. LED-based photonic devices described herein may be configured with suitable power to provide irradiances as high as 100 mW/cm2 or 200 mW/cm2 in the desired wavelength range. An LED array in this device can be incorporated into an irradiation head, hand piece, and/or as an external unit.
In addition to various sources of light, the principles of the present disclosure are also applicable to one or more other types of directed energy sources. As used herein, a directed energy source may include any of the various light sources previously described, and/or an energy source capable of providing one or more of heat, IR heating, resistance heating, radio waves, microwaves, soundwaves, ultrasound waves, electromagnetic interference, and electromagnetic radiation that may be directed to a target body tissue. Combinations of visual and non-visual electromagnetic radiation may include peak wavelengths in a range from 180 nm to 4,000 nm. Illumination devices as disclosed herein may include a light source and another directed energy source capable of providing directed energy beyond visible and UV light. In other embodiments, the other directed energy source capable of providing directed energy beyond visible and UV light may be provided separately from illumination devices of the present disclosure.
Exemplary illumination devices as described herein may be configured to treat tissues within a variety of body cavities. For example, the devices described herein may be configured to treat, prevent, and/or reduce the biological activity of pathogens along tissues of the upper respiratory tract that are accessible via the oral cavity. Such tissues include the pharynx and/or the oropharynx, trachea, and/or esophagus. Representative types of illumination devices described herein may be suitable for positioning at or partially within a patient's mouth for delivery of light to the target tissues.
In certain aspects, illumination devices are disclosed for providing phototherapy in the form of one or more treatment protocols for one or more intended biological effects. As used herein, treatment protocols may also be referred to as light treatment protocols or phototherapy protocols and may include one or more wavelengths of light with corresponding dosing parameters. Depending on the intended biological effect, certain treatment protocols may have limitations on the total amount of dosing required. Certain treatment protocols may vary in dosing and or the administered wavelength of light for a particular biological effect. In certain aspects, illumination devices are disclosed with modular structures that provide the ability to have various changeable attributes, including controlling and/or extending dosing parameters and/or the ability to change administered wavelengths. In this manner, illumination devices are disclosed that may be repeatably modified to tailor light treatments for a variety of biological effects. For example, a modular structure of an illumination device may be configured for treatment of influenza while a different modular structure for the same illumination device may be configured for treatment of coronaviridae.
Modular structures may include tokens, switches, handles, rechargeable power structures, control modules, illumination modules, optics, light guides, and/or light guide positioners, among others. Additionally, the use of modular structures may improve manufacturability of illumination devices and/or reduce overall weights and/or form factors of illumination devices. In certain embodiments, illumination devices may embody connected devices that are part of larger systems that administer and/or monitor light treatment protocols across multiple illumination devices in one or more geographic locations, such as those described in U.S. Publication No. 2022/0212031, the contents of which are incorporated by reference herein in their entirety.
In certain embodiments, modular structures include tokens for providing a controlled number of uses based on a particular treatment protocol. For example, a treatment protocol may involve a certain number of doses to be provided over a certain number of days, after which the illumination device may be programmed to be no longer operable. For additional treatments, a user may replace the existing token of the illumination device with a new one that initiates continued or additional treatments. In certain embodiments, tokens may be provided as a prescription from a medical provider, while in other embodiments, tokens may be provided in over-the-counter form. Switches for initiating operation of the illumination device may be integrated with such tokens in certain embodiments. Modular structures may also include various modules for changing treatment protocols of a particular illumination device, such as illumination modules that provide different wavelengths of light. Additional modular structures may include power structures, such as rechargeable handles and/or communication modules that provide the ability to wireless communication with larger connected systems. Tokens as described above may be integrated within any of the modular structures for initiating and/or controlling treatment protocols.
The light guide 14 may further include a tongue depressor 16 or analogous feature for displacing a user's tongue when inserted into the user's mouth. The tongue depressor 16 may be formed as an extension of the light guide 14 that is curved downward from the light guide 14. In certain aspects, the tongue depressor 16 is an integral single piece with the light guide 14. The light guide 14 and tongue depressor 16 may be formed of a rigid material, such as rigid plastic materials, to not deform when positioned within the oral cavity. Rather, the light guide 14 and the tongue depressor 16 may serve to displace soft tissue, including the tongue, to provide a more direct path for light to target tissue, such as a back of a user's throat or oropharynx.
In certain embodiments, the light guide 14 forms a hollow core that defines a light-transmissive pathway for propagating light toward a target surface. The hollow core may be formed by light-reflective and/or light-blocking walls of the light guide 14. An exemplary configuration includes hollow cylindrical walls of the light guide 14. In certain aspects, the walls of the light guide 14 may be formed with materials that are white in color to promote light-reflective and/or light-redirecting properties. In further aspects, interior surfaces of the walls of the light guide 14 may be formed with textured or roughened features for redirecting and/or scattering light in various directions as the light propagates along the light guide 14. By arranging the light guide 14 with the hollow core, increased amounts of light may exit the light guide 14 along a direct path without interacting with the walls, while wider-angled light may be reflected and/or redirected by the light guide 14. The light guide 14 may include a flange 18 that facilitates attachment with the housing 12, such as by way of a snap-fit connection.
A light guide positioner 20 may be arranged about a periphery of a portion of the light guide 14. The light guide positioner 20 may be adapted for engaging with one or more surfaces within the oral cavity to secure the illumination device 10 and direct emissions through the light guide 14 in a desired direction. In such embodiments, the light guide positioner 20 may also be referred to as a mouthpiece. In
A user interface element 26, such as a tactile element, button, or switch, may be positioned along the housing 12 so that a user may initiate operation of the illumination device 10. The housing 12 may form a handle 12′ for a user to hold during use and the user interface element 26 may be positioned on the handle 12′. In certain embodiments, a window 28 through the housing 12 may be arranged to provide visible indication that the light sources within the housing 12 are illuminated. As used herein, the window 28 may also be referred to as a housing window. This allows the user to know the illumination device 10 is functioning while the light guide positioner 20 and portions of the light guide 14 are inserted into the oral cavity during use. The window 28 may comprise an opening of the housing 12 proximate a location of the internal light source and spaced away from a primary emission surface of the illumination device 10. In the context of the illumination device 10, the primary emission surface is an end of the light guide 14 that is distal to the housing 12. In this regard, the window 28 is spaced away from the light guide positioner 20 and the light guide 14. In certain embodiments, the window 28 may comprise a light transparent material, such as silicone, plastic, or glass. The housing 12 may also include a port 30 that may be a charging port and/or a data transfer port, such as a universal serial bus (USB) port.
As illustrated in the cross-sectional view of
The illumination device 10 may further include a lens 50 positioned between the light guide 14 and the one or more light sources 40. The lens 50 may be useful for controlling and directing an emission pattern from the one or more light sources 40 into the light guide 14. In certain embodiments, a portion of the lens 50, such as an apex of the lens 50, may at least partially reside within the light guide 14 to further direct emissions. A lens retainer 52 may further be arranged between the light guide 14 and the one or more light sources 40 to hold the lens 50 in place. In certain embodiments, a spacer 54 may be arranged to extend between the lens 50 and the one or more light sources 40 to position the lens 50 at a suitable distance. In this manner, the lens 50 may be sandwiched between the lens retainer 52 and the spacer 54. In certain embodiments, the spacer 54 may have an opening that is aligned with the window 28 for providing visual indication of when the one or more light sources 40 are electrically activated. In this manner, the window 28 is positioned to received light emitted from the one or more light sources 40 that is offset from a primary emission direction through the light guide 14, such as at least 45 degrees or in a range of 45 degrees to 90 degrees offset from the primary emission direction.
As best illustrated in
As further illustrated in
As previously described, certain embodiments of illumination devices may embody connected devices that are in communication with larger systems that administer, monitor, and/or analyze light treatment protocols across multiple illumination devices in one or more geographic locations. Illumination devices as disclosed herein may be in communication with one or more external devices, such as one or more local devices, networks, and/or servers. Local devices include various local computing devices, such as computers, tablets, and mobile devices, as well as applications on such local devices. Networks may refer to any medium or architecture capable of facilitating communication or data transfer. Examples of the networks include, without limitation, an intranet, a wide area network (WAN), a local area network (LAN), a personal area network (PAN), the Internet, power line communications (PLC), a cellular network (e.g., a global system for mobile communications (GSM) network), or the like. Servers may include server-side applications that collect usage data from illumination devices and/or provide information, such as treatment protocols, back to the illumination devices. Communication between illumination devices as described herein and one or more of the local devices, servers, and networks may involve communication or data transfer using wireless or wired connections.
As illustrated in
It is contemplated that any of the foregoing aspects, and/or various separate aspects and features as described herein, may be combined for additional advantage. Any of the various embodiments as disclosed herein may be combined with one or more other disclosed embodiments unless indicated to the contrary herein.
Those skilled in the art will recognize improvements and modifications to the preferred embodiments of the present disclosure. All such improvements and modifications are considered within the scope of the concepts disclosed herein and the claims that follow.